Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1976 3
1978 3
1979 2
1980 4
1981 7
1982 4
1983 4
1984 3
1985 3
1986 3
1987 4
1988 5
1990 1
1991 1
1992 5
1993 4
1994 2
1995 7
1996 3
1997 3
1999 2
2000 6
2001 5
2002 9
2003 1
2004 1
2005 5
2006 10
2007 7
2008 12
2009 8
2010 14
2011 3
2012 5
2013 8
2014 12
2015 12
2016 9
2017 6
2018 9
2019 13
2020 15
2021 20
2022 16
2023 17
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

273 results

Results by year

Filters applied: . Clear all
Page 1
Telmisartan, ramipril, or both in patients at high risk for vascular events.
ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. ONTARGET Investigators, et al. N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31. N Engl J Med. 2008. PMID: 18378520 Free article. Clinical Trial.
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators; Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P. Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, et al. Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Lancet. 2008. PMID: 18757085 Clinical Trial.
Autonomic Regulation of Inflammation in Conscious Animals.
Salgado HC, Brognara F, Ribeiro AB, Lataro RM, Castania JA, Ulloa L, Kanashiro A. Salgado HC, et al. Among authors: ribeiro ab. Neuroimmunomodulation. 2023;30(1):102-112. doi: 10.1159/000530908. Epub 2023 May 5. Neuroimmunomodulation. 2023. PMID: 37232031 Free article. Review.
[Drug therapy].
Kohlmann O Jr, Gus M, Ribeiro AB, Vianna D, Coelho EB, Barbosa E, Almeida FA, Feitosa G, Moreno H, Guimarães JI, Ribeiro JP, Ramirez JA, Martins JF, Santos RA; Sociedade Brasileira de Cardiologia; Sociedade Brasileira de Hipertensão; Sociedade Brasileira de Nefrologia. Kohlmann O Jr, et al. Among authors: ribeiro ab. J Bras Nefrol. 2010 Sep;32 Suppl 1:29-43. doi: 10.1590/s0101-28002010000500008. J Bras Nefrol. 2010. PMID: 22262210 Free article. Portuguese. No abstract available.
SGLT-2 inhibitors in diabetes: a focus on renoprotection.
Gonzalez DE, Foresto RD, Ribeiro AB. Gonzalez DE, et al. Among authors: ribeiro ab. Rev Assoc Med Bras (1992). 2020 Jan 13;66Suppl 1(Suppl 1):s17-s24. doi: 10.1590/1806-9282.66.S1.17. Rev Assoc Med Bras (1992). 2020. PMID: 31939531 Free article. Review.
Blood pressure disturbance in diabetes mellitus.
Zanella MT, Freire MB, Milagres R, Ferreira S, Bonomo PP, Kohlmann O Jr, Ribeiro AB. Zanella MT, et al. Among authors: ribeiro ab. J Hypertens Suppl. 1992 Dec;10(7):S59-70. J Hypertens Suppl. 1992. PMID: 1291658 Review.
Hypertension and diabetes. Clinical problems.
Zanella MT, Santiago RC, de Sá JR, Salgado BJ, de Faria SF, Peres RB, Kohlmann Júnior O, Ribeiro AB. Zanella MT, et al. Among authors: ribeiro ab. Drugs. 1988;35 Suppl 6:135-41. doi: 10.2165/00003495-198800356-00018. Drugs. 1988. PMID: 3042352 Review.
Uric acid as a factor in the metabolic syndrome.
Borges RL, Ribeiro AB, Zanella MT, Batista MC. Borges RL, et al. Among authors: ribeiro ab. Curr Hypertens Rep. 2010 Apr;12(2):113-9. doi: 10.1007/s11906-010-0098-2. Curr Hypertens Rep. 2010. PMID: 20424936 Review.
Antitumor Effect of Manool in a Murine Melanoma Model.
Nicolella HD, Ribeiro AB, Melo MRS, Ozelin SD, Domingos da Silva LH, Sola Veneziani RC, Crispim Tavares D. Nicolella HD, et al. Among authors: ribeiro ab. J Nat Prod. 2022 Feb 25;85(2):426-432. doi: 10.1021/acs.jnatprod.1c01128. Epub 2022 Feb 14. J Nat Prod. 2022. PMID: 35157797
273 results